Scale
Finance and First Flight Venture Center are joining together for a timely, and
useful discussion on no-dilutive funding for life science companies. A
distinguished panel of local successes will be gathered at American
Underground in Durham on Oct. 8 to give startups insight, and ideas, on how
to start and grow life science endeavors with limited cash flow.
Bootstrapping for a period of time allows companies to raise capital in the future and at better terms. The trick for life science and medical device companies is to identify early sources of alternative non-dilutive capital to move the business as far as you can before seeking the larger amounts of capital that will eventually be needed.
The forum panel includes the following well-known leaders:
Bootstrapping for a period of time allows companies to raise capital in the future and at better terms. The trick for life science and medical device companies is to identify early sources of alternative non-dilutive capital to move the business as far as you can before seeking the larger amounts of capital that will eventually be needed.
The forum panel includes the following well-known leaders:
- Rich West, currently co-founder and CEO of his fourth life sciences startup, which is focused on newborn screening (www.baebies.com)
- Peyton Anderson, CEO of Affinergy, a Duke spinout commercializing medical devices and is Chairman of Powered Research, a preclinical CRO
- Sam Tetlow, CEO of EpiCypher
- Dr. Eva Garland, VP of R&D for Agile Sciences
- Gary Hayes, COO and Co-Founder of Scale Finance
Register
for the event here
Read
the full press release here
No comments:
Post a Comment